A novel virotherapy encoding human interleukin-7 improves ex vivo t lymphocyte functions in immunosuppressed patients with septic shock and critically ill covid-19

HIGHLIGHTS

• who: Morgane Crausaz from the Louisiana State University, United States have published the article: A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19, in the Journal: (JOURNAL)
• what: According to the Etablissement franç ais du sang(EFS) standardized procedures for blood donation and to the provisions of the article R.1243-49 and following the French public health code, a written non-opposition to the use of donated blood for research purposes was obtained from HVs. The authors assessed the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.